Qure.ai

AI: A Game-Changer in Pulmonology  Identifying Incidental Pulmonary Nodules (IPNs) early is critical for improving patient outcomes. However, subtle nodules are sometimes missed in traditional CXR reviews. Enter Artificial Intelligence (#AI) – a transformative force in #lungcancer detection. AI-powered algorithms can:  - Detect clinically relevant IPNs with unmatched accuracy  - Identify nodules missed in up to 70% of radiographs  - Enable earlier diagnostic bronchoscopies, accelerating treatment AI doesn’t replace #radiologists or #pulmonologists—it enhances their ability to save lives. By integrating AI into pulmonary workflows, we can reduce delays, optimize diagnosis, and ultimately improve survival rates. What are your thoughts on AI’s role in #lungcancerdetection? Let’s discuss ⬇️ #AIInHealthcare #MedicalInnovation 

"𝙒𝙚 𝙖𝙧𝙚 𝙘𝙤𝙢𝙢𝙞𝙩𝙩𝙚𝙙 𝙩𝙤 𝙖𝙞𝙙𝙞𝙣𝙜 𝙝𝙚𝙖𝙡𝙩𝙝𝙘𝙖𝙧𝙚 𝙥𝙧𝙤𝙛𝙚𝙨𝙨𝙞𝙤𝙣𝙖𝙡𝙨 𝙞𝙣 𝙙𝙞𝙖𝙜𝙣𝙤𝙨𝙞𝙣𝙜 𝙞𝙡𝙡𝙣𝙚𝙨𝙨𝙚𝙨 𝙛𝙖𝙨𝙩𝙚𝙧 𝙖𝙣𝙙 𝙬𝙞𝙩𝙝 𝙢𝙤𝙧𝙚 𝙙𝙚𝙩𝙖𝙞𝙡 𝙖𝙣𝙙 𝙖𝙘𝙘𝙪𝙧𝙖𝙘𝙮 𝙬𝙝𝙞𝙡𝙚 𝙖𝙪𝙩𝙤𝙢𝙖𝙩𝙞𝙣𝙜 𝙧𝙤𝙪𝙩𝙞𝙣𝙚 𝙬𝙤𝙧𝙠. 𝙏𝙝𝙞𝙨 𝙞𝙨 𝙖 𝙬𝙞𝙣 𝙛𝙤𝙧 𝙝𝙚𝙖𝙡𝙩𝙝𝙘𝙖𝙧𝙚 𝙥𝙧𝙤𝙛𝙚𝙨𝙨𝙞𝙤𝙣𝙖𝙡𝙨 𝙖𝙣𝙙 𝙥𝙖𝙩𝙞𝙚𝙣𝙩𝙨 𝙜𝙡𝙤𝙗𝙖𝙡𝙡𝙮." - 𝙋𝙧𝙖𝙨𝙝𝙖𝙣𝙩 𝙒𝙖𝙧𝙞𝙚𝙧  ⭐ Detecting abnormalities on scans is a complex task. How can AI expedite diagnoses for patients and healthcare workers? This Founder Friday, we explore the journey of Prashant Warier, who founded Qure.ai to leverage deep learning and artificial intelligence in radiology, making healthcare more accessible and equitable. 🧠 Qure.ai was built to enhance imaging accuracy and improve global health outcomes. Their AI tools automate X-rays, CTs, and ultrasound scans, enabling faster diagnosis and improved workflows.  🩺 Qure.ai offers powerful solutions for tuberculosis care, lung cancer detection, and stroke management. Their AI-driven platform is recognized for its accuracy and is deployed worldwide, enhancing TB detection rates and streamlining healthcare workflows. By rapidly identifying TB, they ensure prompt treatment, saving lives and maximizing healthcare efficiency. 🚀 Qure.ai is advancing stroke care with their AI-powered Stroke Care Suite. The qER AI algorithm and Qure App send immediate high-priority alerts upon stroke diagnosis, ensuring early specialist involvement and seamless coordination for improved patient outcomes. Learn more about how Qure.ai is setting new standards in diagnosis and treatment: https://www.qure.ai/    #FounderFridays

Qure.ai has been evaluated to INCREASE #TB detection, while SAVING costs as compared to status quo ! The holy grail in any #publichealth initiative. With the BEST #Health #Technology Assessment results among all, Central Drugs Standard Control Organization cleared TB #AI vendors in India. We are extremely grateful for the role Indian Council of Medical Research (ICMR) plays in ensuring Indians get only safe and effective health solutions, and look forward to joining forces for a #TBMuktBharat.     https://lnkd.in/d9bB-rXZ

#Lungcancer does not wait and neither should #earlydetection. By the time symptoms appear, treatment options shrink. But what if we could shift the timeline? With #AI and #healthcare professionals working together, we can spot the earliest signs, helping doctors act sooner when it matters most. Because in the race against #lung #cancer, early always wins! Visit https://lnkd.in/d5bJCKFU to know more. 

Welcome to our new #AI Super Users in the UK NHS! Each AI deployment is followed with training to ensure a minimum standard of knowledge for use in daily clinical practice to improve clinical workflows, empower #healthcare professionals and enhance a standard of care for patients.    Qure.ai Super Users gain a Continuing Professional Development (CPD) certificate of endorsement by The College of Radiographers and credits in accordance with the CPD scheme of The Royal College of Radiologists. 

Every second counts in #strokecare—delays in treatment can cost lives.    At World #Stroke Congress 2024, Team Qure.ai, in collaboration with Zeenat Qureshi Stroke Institutes (ZQSI), presented a study demonstrating how #AI can accelerate decision-making for Mechanical Thrombectomy (MT) eligibility using only Non-Contrast CT (NCCT), CT Angiography (CTA), and simple clinical inputs.    Key finding: #AI correctly predicted 98% of truly eligible patients, reducing reliance on advanced imaging and enabling faster treatment decisions.    This AI-powered approach could be a game-changer for stroke care—facilitating earlier transfers, quicker cath lab activation, and more timely, life-saving treatment.    Read the full study here: https://lnkd.in/d_8eKkSv

As the #AIActionSummit kicks off in Paris, co-hosted by #India and #France, the spotlight is on India’s growing #AI leadership. With PM Narendra Modi and President Emmanuel Macron in attendance, this #global stage highlights India’s rise as a #tech powerhouse. India ranks 10th globally in private AI investments. In this FRANCE 24 (Alban Alvarez) feature, explore how India is building its AI arsenal across sectors like #healthcare, robotics, and language technologies. Proud to have Qure.ai highlighted for driving real-world impact with AI! PS: Divya Gupta, our Chief Business Officer for #GlobalHealth, will be speaking at #AIinHealthcare, a full-day #summit co-organized by the European Commission (EU Health and Food Safety) and Health Data Hub. Join her if you’re in Paris! Link to the news story: https://lnkd.in/eXyg_vTU

Feb 4 is World Cancer Day. Cancer is personal and we at AstraZeneca believe treatment should be too. Innovative approaches like computational pathology can help predict the right treatment path, and I’ve been encouraged to see recent positive impacts in lung cancer. Aided by artificial intelligence, we are also witnessing significant progress in early diagnosis, particularly in lung cancer screening. As the Lung Ambition Alliance recently shared, an AI-enabled chest X-ray has helped with the early detection of lung cancer in Malaysia. Equitable access to these developments will pave the way to earlier diagnosed cancers that are more efficiently treated, a benefit for patients, societies and health systems.  Learn how AstraZeneca is shaping the future of computational pathology in this article by my colleague, Susan Galbraith, EVP, Oncology Haematology R&D. 👇 https://lnkd.in/e62RQX_Q  #WorldCancerDay #UnitedByUnique 

We were honored to join a session on #AI’s role in strengthening PHCs, exploring its impact on disease detection. Dr. Shibu Vijayan shared how AI is transforming #lunghealth, #cancer screening, NCD care, and continuous care for patients—ensuring #earlydetection and personalized treatment. Looking forward to see these #innovations shape the #futureofhealthcare. PATH | Gates Foundation | Neeraj Jain | Nabeel Goheer | Bilal A Mateen | Kimberly Green | Katharine Shelley | Sameer Kanwar | Alain Labrique | Jonas Karlström | Oommen John | Marelize Gorgens Prestidge | Ricardo Baptista Leite, M.D. | Dr. Priyanka Bajaj

Qure.ai is at BRONCHUS 2025! Yashoda Hospitals Swing by our booth to explore how #AI is transforming incidental pulmonary nodule (IPN) detection and management. Our team will share insights on how AI empowers thoracic doctors and #pulmonologists to detect, track, and manage on IPNs early, improving lung cancer outcomes. Don’t miss our speaker sessions!